MET and neoplasm: Daily treatment with the MET inhibitor SU11274 caused statistically significant interval retardation of the xenograft tumour growth of H1975 cells with a ninefold reduction (P=0.0251) in the xenograft growth, when compared with the diluent control, during the treatment period (Figure 3A-a,b).